Approach to the patient with malaria

J. Kevin Baird, Erni J. Nelwan, W. Robert Taylor

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

Nearly 3 billion people live at risk of malaria across most of the tropics, subtropics, and even some temperate zones. Millions visit these areas, and each year thousands appear in hospitals with posttravel acute malaria. That diagnosis should be managed as a medical emergency. Illness may deteriorate rapidly without prompt diagnosis and effective treatment. Among five species of Plasmodium responsible for human malaria, Plasmodium falciparum most often deteriorates rapidly, but all species potentially threaten life. Malignant and benign species of malaria parasites is a dangerous fallacy. Clinical malaria mimics other common tropical infections and the diagnosis requires laboratory confirmation, but malaria-like symptoms in a patient exposed to risk should be presumed to be malaria until proven otherwise. Intravenous or intramuscular artesunate is used for severe malaria of any species in any patient, including all trimesters of pregnancy. Primaquine is administered with vivax or ovale malarias after affirming glucose-6-phosphate dehydrogenase (G6PD)-normal status.

Original languageEnglish
Title of host publicationTravel Medicine
PublisherElsevier
Pages179-186
Number of pages8
ISBN (Electronic)9780323546966
DOIs
Publication statusPublished - 1 Jan 2018

Keywords

  • Artesunate
  • Clinical diagnosis
  • Differential diagnosis
  • G6PD deficiency
  • Laboratory diagnosis
  • Malaria
  • Primaquine
  • Severe malaria
  • Traveler
  • Treatment
  • Uncomplicated malaria

Fingerprint Dive into the research topics of 'Approach to the patient with malaria'. Together they form a unique fingerprint.

Cite this